Search

everythinglearnresearchcommunity

for

Search:↓

FDA-approved low-level light/laser therapy devices can significantly increase hair density in people with pattern hair loss.

The FDA approved a new Pfizer drug for hair loss in teens.

FDA-approved medications are important for treating high blood pressure in children, but non-approved ones can be used if needed.

Some JAK inhibitors are effective for significant hair regrowth in alopecia areata.

Some medications can help increase sexual desire and function in women.

The FDA approved using Cialis with Proscar for better treatment options.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Five FDA-approved drugs may help block COVID-19 virus entry.

Apremilast shows promise for several skin conditions but needs more research.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

More effective treatments are needed for alopecia areata, hidradenitis suppurativa, and vitiligo.

Five FDA-approved drugs may help block COVID-19 virus entry.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

Pranlukast and mirabegron may work as new diabetes drugs.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Generic topical and transdermal systems usually cause minimal irritation or sensitization.

Dutasteride is highly effective for hair loss treatment in Korea, with more side effects than finasteride.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Finasteride, a hair loss medication, may be linked to stroke in young men.

Cepharanthine could be a strong antiviral against COVID-19.

The methods accurately measure finasteride and tadalafil in Entadfi™ capsules for quality control.

In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.